Skip to main content

LDN and Multiple Sclerosis


Pamela Smith, MD


Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central nervous system. This interactive session will examine a personalized medicine approach to multiple sclerosis. Multiple sclerosis occurs more commonly in the northern latitudes. Furthermore, it is estimated that 10-15 genes may affect the risk of a patient developing MS. Women are more commonly affected than men. Women are 60% of the cases of multiple sclerosis. This seminar will review both conventional and functional medicine approaches to multiple sclerosis along with the newest therapy: low dose naltrexone.


  • Know the risk factors for multiple sclerosis
  • Recognize how diet affects multiple sclerosis
  • Learn traditional therapies for multiple sclerosis
  • Learn metabolic treatments for multiple sclerosis
  • Recognize the symptoms of multiple sclerosis
  • Understand the role that LDN plays in multiple sclerosis therapy